/wp-content/uploads/2021/10/logo_color.svg00raincastle/wp-content/uploads/2021/10/logo_color.svgraincastle2020-07-17 15:38:582021-12-20 13:34:11STAT News | Startup Spotlight: Glympse Bio hopes its test will show whether drugs are actually working
/wp-content/uploads/2021/10/logo_color.svg00raincastle/wp-content/uploads/2021/10/logo_color.svgraincastle2020-07-15 15:42:072021-12-20 13:34:20360Dx | Glympse Bio Closes $46.7M Series B Financing
/wp-content/uploads/2021/10/logo_color.svg00raincastle/wp-content/uploads/2021/10/logo_color.svgraincastle2020-07-15 15:41:502021-12-20 13:34:29BioSpace | Glympse Bio Secures $46.7 Million to Advance NASH Biosensor Program
/wp-content/uploads/2021/10/logo_color.svg00raincastle/wp-content/uploads/2021/10/logo_color.svgraincastle2020-07-15 15:40:562021-12-20 13:34:59Fierce Biotech | Glympse Bio secures $46M to boost its injectable diagnostics for NASH, cancer & more
/wp-content/uploads/2021/10/logo_color.svg00raincastle/wp-content/uploads/2021/10/logo_color.svgraincastle2020-07-15 15:40:322021-12-20 13:35:08MedCity News | Glympse Bio raises more than $46M in Series B round for biosensor technology
/wp-content/uploads/2021/10/logo_color.svg00raincastle/wp-content/uploads/2021/10/logo_color.svgraincastle2020-07-15 15:40:002021-12-20 13:36:17BioCentury | Glympse raises $47.6M to test biosensors that could improve on liver biopsies in NASH
/wp-content/uploads/2021/10/logo_color.svg00raincastle/wp-content/uploads/2021/10/logo_color.svgraincastle2020-07-15 14:55:002021-10-27 14:55:47Glympse Bio Announces $46.7 Million Series B Financing
